📰 Industry Classification Benchmark News
Page 4 - Industry Classification Benchmark News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Industry Classification Benchmark. Real-time updates on events, politics, business and more.
February 28, 2024
Mutual Advisors LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 51.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,687 shares of the financial services provider’s stock after selling 12,579 shares during the quarter. Mutual Advisors LLC’s holdings in […]
February 27, 2024
Itau Unibanco Holding S.A. acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 394,485 shares of the financial services provider’s stock, valued at approximately $48,242,000. iShares Biotechnology ETF comprises 2.2% of Itau […]
February 27, 2024
Itau Unibanco Holding S.A. acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 394,485 shares of the financial services provider’s stock, valued at approximately $48,242,000. iShares Biotechnology ETF makes up approximately 2.2% […]
February 25, 2024
Jacobi Capital Management LLC raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 2,539 shares of the financial services provider’s stock after acquiring an additional 91 shares during the period. Jacobi Capital […]
February 25, 2024
Jacobi Capital Management LLC raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 2,539 shares of the financial services provider’s stock after acquiring an additional 91 shares during the period. Jacobi Capital […]
February 23, 2024
EPG Wealth Management LLC lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 82.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,982 shares of the financial services provider’s stock after selling 14,214 shares during the quarter. EPG […]
February 20, 2024
Healthcare of Ontario Pension Plan Trust Fund lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 29.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 499,000 shares of the financial services provider’s stock after selling […]
February 14, 2024
Blair William & Co. IL cut its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 0.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 45,747 shares of the financial services provider’s stock after selling 218 shares during the period. Blair William & Co. IL […]
February 9, 2024
Janney Montgomery Scott LLC cut its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 8.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 97,753 shares of the financial services provider’s stock after selling 8,859 shares during the quarter. Janney Montgomery Scott LLC […]
February 2, 2024
Clearstead Advisors LLC raised its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 47.7% in the third quarter, HoldingsChannel.com reports. The firm owned 1,115 shares of the financial services provider’s stock after purchasing an additional 360 shares during the quarter. Clearstead Advisors LLC’s holdings in iShares Biotechnology ETF were worth $136,000 […]